1. Home
  2. YEXT vs DNTH Comparison

YEXT vs DNTH Comparison

Compare YEXT & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YEXT
  • DNTH
  • Stock Information
  • Founded
  • YEXT 2006
  • DNTH 2015
  • Country
  • YEXT United States
  • DNTH United States
  • Employees
  • YEXT N/A
  • DNTH N/A
  • Industry
  • YEXT EDP Services
  • DNTH Biotechnology: Pharmaceutical Preparations
  • Sector
  • YEXT Technology
  • DNTH Health Care
  • Exchange
  • YEXT Nasdaq
  • DNTH Nasdaq
  • Market Cap
  • YEXT 786.1M
  • DNTH 724.8M
  • IPO Year
  • YEXT 2017
  • DNTH N/A
  • Fundamental
  • Price
  • YEXT $6.21
  • DNTH $17.86
  • Analyst Decision
  • YEXT Strong Buy
  • DNTH Strong Buy
  • Analyst Count
  • YEXT 3
  • DNTH 8
  • Target Price
  • YEXT $9.00
  • DNTH $54.33
  • AVG Volume (30 Days)
  • YEXT 852.9K
  • DNTH 388.4K
  • Earning Date
  • YEXT 03-05-2025
  • DNTH 05-08-2025
  • Dividend Yield
  • YEXT N/A
  • DNTH N/A
  • EPS Growth
  • YEXT N/A
  • DNTH N/A
  • EPS
  • YEXT N/A
  • DNTH N/A
  • Revenue
  • YEXT $420,957,000.00
  • DNTH $6,235,000.00
  • Revenue This Year
  • YEXT $9.70
  • DNTH N/A
  • Revenue Next Year
  • YEXT $4.40
  • DNTH N/A
  • P/E Ratio
  • YEXT N/A
  • DNTH N/A
  • Revenue Growth
  • YEXT 4.11
  • DNTH 120.63
  • 52 Week Low
  • YEXT $4.29
  • DNTH $16.44
  • 52 Week High
  • YEXT $8.75
  • DNTH $32.27
  • Technical
  • Relative Strength Index (RSI)
  • YEXT 44.09
  • DNTH 38.62
  • Support Level
  • YEXT $6.07
  • DNTH $16.44
  • Resistance Level
  • YEXT $6.30
  • DNTH $20.45
  • Average True Range (ATR)
  • YEXT 0.18
  • DNTH 1.69
  • MACD
  • YEXT -0.00
  • DNTH -0.28
  • Stochastic Oscillator
  • YEXT 28.57
  • DNTH 23.16

About YEXT Yext Inc.

Yext Inc provides a knowledge engine platform that lets businesses manage their digital knowledge in the cloud and sync it to approximately 200 services including Apple Maps, Bing, Cortana, Facebook, Google, Google Maps, Instagram, Siri and Yelp. Digital knowledge is the structured information that a business wants to make publicly accessible. The company also makes search intelligent by helping to provide precise, accurate and current answers to location-based queries that are conducted across the web and mobile applications and voice and artificial intelligence, or AI, engines. The company derives the majority of its revenues from subscription services. Geographically, the company generates a majority of its revenue from North America and the rest from International markets.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

Share on Social Networks: